Free Stipulation - District Court of Delaware - Delaware

Case 1 :04-cv-00171-GMS Document 87 Filed 05/10/2006 Page 1 of 3
IN THE UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF DELAWARE
-·-• ---— ·••—- -—--—- --·-——··· ------ •·•··-·-•·····—-· -——----—---—- -·-·•·-··X
GLAXO GROUP LIMITED :
Plaintiff Civil Action No. O4-171-KAJ
V. Z
TEVA PHARMACEUTICALS USA, INC. and
TEVA PHARMACEUTICAL INDUSTRIES :
LIMITED 2
Defendants. :
............ - .........................._._..................._. Q.
STIPULATION REGARDING AUTHENTICITY
AND ADMISSIBILITY OF DOCUMENTS AND TESTIMONY
WHEREAS, the Glaxo Group Limited ("Glaxo") and Teva Pharmaceuticals USA, Inc.
and Teva Pharmaceutical Industries Limited (collectively, "Teva") have reached an agreement
regarding the authenticity and admissibility of certain documents and testimony,
IT IS HEREBY STIPULATED and ORDERED that:
I. All documents identified in Appendix A attached hereto are authentic and
admissible: evidence in this case. The parties may use any document identified in Appendix A in
dispositive motions or at trial, in whole or in part, subject to the right of the other party to
designate and/or admit additional portions of any document for context and completeness.
2. The trial transcript of all trial testimony given by the following Glaxo witnesses in
Glaxo v. Pharmadyne, 32 F . Supp.2d 265 (D. Md. 1998), and all related documents that were
admitted into evidence as trial exhibits, are admissible evidence in this case:
l

Case 1:04-cv-00171—Gl\/IS Document 87 Filed 05/10/2006 Page 2 of 3
• Dr. John R. Wood (Teva reserves the right to contest its admissibility, in
whole or in part, as irrelevant or prejudicial);
• Dr. David R. Long;
• Dr. John Malcolm Padiield; and
• Dr. John Hempenstall.
3. The transcript of all deposition testimony of the following Glaxo witnesses in
Glaxo v. Pharmadyne, 32 F. Supp.2d 265 (D. Md. 1998), and all Glaxo documents that were
marked as deposition exhibits during those depositions, are admissible evidence in this case:
¤ Dr. David Long;
• Dr. John Malcolm Padiield;
• Dr. John Hempenstallg
• Dr. Ian Winterborn;
• Gillian Amphlett; and
• Nadeem Elahi. I
2

Case 1:04-cv-00171—G|\/IS Document 87 Filed 05/10/2006 Page 3 of 3
AGREED AS TO FORM AND SUBSTANCE:
Dated: May/Q, 2006 Dated: May,/g, 2006
For Plaintiff GLAXO GROUP LIMITED For Defendants TEVA
PHARMACEUTICALS USA, INC. and
TEVA PHARMACEUTICAL
INDUSTRIES LIMITED
By: /5l Ffomglg l>{G1`o\{@nn{ By: ( ,§
Francis DiGiovanni (#3189) J z W. ngersol f '1088)
CONNOLLY BOVE LODGE YOUN CONAWAY STARGATT
& HUTZ LLP & TAYLOR, LLP
The Nemours Building The Brandywine Building
1007 North Orange Street 1000 West Street, 17th Floor
P.O. Box 2207 P.O. Box 391
Wilmington, DE 19899-2207 Wilmington, DE 19899-0391
(302) 8:88-6316 (302) 571-6600
OF COUNSEL: OF COUNSEL:
Brian P. Murphy Mark D. Schuman
Thomas J. Puppa Jeffrey C. Brown
Bryan J. Vogel MERCHANT & GOULD
MORGAN, LEWIS & BOCKIUS LLP 3200 IDS Center
101 Park Avenue 80 South 8th Street
New York, NY 10178-0060 Minneapolis, MN 55402
(212) 309-6000 (612) 332-5300
Attorneys for Plaintiff Glaxo Group Attomeys for Defendants Teva
Limited Pharmaceuticals USA, Inc. and Teva
Phannaceutical Industries Limited
SO ORDERED this day of 2006.

UNITED STATES DISTRICT JUDGE
3

Case 1:04-cv-00171-GMS

Document 87

Filed 05/10/2006

Page 1 of 3

Case 1:04-cv-00171-GMS

Document 87

Filed 05/10/2006

Page 2 of 3

Case 1:04-cv-00171-GMS

Document 87

Filed 05/10/2006

Page 3 of 3